CONTINUUS Pharmaceuticals
Tom van Laar received his B.S. In Chemical Engineering from Rensselaer Polytechnic Institute and an MBA from Northwestern University (Kellogg). He began a long career in manufacturing with Sybron Corporation and GE Plastics before beginning to work in pharmaceuticals with Searle for 19 years (Searle was bought by Monsanto and later became Pharmacia). Tom joined Novartis in 2002 as head of US manufacturing for the Pharma division and was promoted in late 2004 to Head of Global Technical Operations based in Basel, Switzerland. Technical Operations had 24 manufacturing sites around the world supporting a $32 bio Pharma business. In addition to his overall operational responsibilities, Tom led the first ever Lean manufacturing and Process Oriented organization transformation in Novartis. In 2007, Tom also initiated the first ever transformation to truly continuous manufacturing for the Pharma industry in partnership with MIT. Tom retired from Novartis in early 2013 to return with his wife to the US. After a 6 month break, he is beginning to consult in the areas of pharmaceutical manufacturing and organizational transformation.
This person is not in the org chart
This person is not in any offices
CONTINUUS Pharmaceuticals
CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. With ICM, they will improve affordability and accessibility of pharmaceuticals on a global scale.